Evaluation of Efficacy and Safety of AQUA-TURMÃ?Â® in Subjects Suffering from Delayed onset muscle soreness (DOMS) Ã¢â?¬â?? A Randomized, Double Blind, Placebo Controlled, Comparative, interventional, Prospective Clinical Study - NI

odaat Pharma0 个研究点目标入组 40 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Moderately active (regular aerobic exercise for at least 4 hours per week) healthy human volunteers
•2.Subjects with no known musculoskeletal pathology
•3.Subjects willing to sign informed consent and to undergo all the study procedure.

•1.Subjects with no known musculoskeletal pathology
•2.Subjects using systemic corticosteroids within 2 months of screening
•3.Subjects with any other investigational drug within 1 month prior to randomization;
•4.Subjects with uncontrolled diabetes mellitus and hypertension
•5.Subjects with known tuberculosis, HIV, ischemic heart disease, cancer, kidney failure
•6.Pregnant and lactating women
•7.Subjects with significant abnormal laboratory parameters
•8.Known hypersensitivity to any of the ingredients of AQUA-TURMÃ?Â®
•9.Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the protocol

发起方

odaat Pharma